| 2型糖尿病三种治疗方案的成本-效果分析 |
| |
| 引用本文： | 唐燕琴.2型糖尿病三种治疗方案的成本-效果分析[J].中国基层医药,2012,19(3):355-356. |
| |
| 作者姓名： | 唐燕琴 |
| |
| 作者单位： | 厦门大学医院药剂科,福建省厦门,361005 |
| |
| 摘 要： | 目的 分析三种用于2型糖尿病(T2DM)治疗方案的效果与成本的关系,以得出最合理的治疗方案.方法 利用药物经济学原理,回顾性分析198例T2DM患者的病例资料,对格列美脲、瑞格列奈、罗格列酮三种用于T2DM的药物进行药物成本-效果分析.结果 三种方案的总有效率没有显著差异,而三种方案的成本-效果比(C/E)分别为:2.99、1.43、5.76,三种方案的增量成本-效果比(△C/△E)分别为:42.15、18.32、214.74.结论 应根据患者的个体差异,选择治疗效果最好,价格最低,安全系数最高的治疗方案.
|
| 关 键 词： | 糖尿病 2型 临床方案 费用 药物 |
Cost-effectiveness analysis of 3 different drugs in the treatment of type 2 diabetes mellitus |
| |
| TANG Yan-qin.Cost-effectiveness analysis of 3 different drugs in the treatment of type 2 diabetes mellitus[J].Chinese Journal of Primary Medicine and Pharmacy,2012,19(3):355-356. |
| |
| Authors: | TANG Yan-qin |
| |
| Institution: | TANG Yan-qin. Department of Pharmacy ,Xiamen University Hospital ,Xiamen , Fujian 361005, China |
| |
| Abstract: | Objective To analyze the cost-effectiveness of the treatment of type 2 diabetes by 3 different drugs. Methods Through the retrospective analysis of 198 cases with T2DM and drug economlcs,to analyze the costeffectiveness of the Yamo Li（ glimepiride）, repaglinide（repaglinide） and Avandia（ rosiglitazone）. Results No significant difference was observed in the total effective rate among the 3 drugs. The cost-effectiveness ratios in Group A, B and C were 2.99,1.43 and 5.76. The cost-effectiveness ratios increments in Group A,B and C were 42. 15,18.32 and 214.74. Conclusion Based on individual differences of the patients, doctor should choose the drug with best treatment, lowest price and highest safety. |
| |
| Keywords: | Diabetes mellitus type 2 Clinical protocols Fees pharmaceutical |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
